Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

fda_21_0

FDA approves Novartis’ MS drug Kesimpta for treating relapsed forms of the disease

August 21, 2020 Medical Communications

The FDA has authorised Novartis’ Kesimpta (ofatumumab) for treating patients with relapsing forms of multiple sclerosis (MS), it has been …
News

NICE recommends combination treatment from Roche for certain lymphoma patients

August 21, 2020 Medical Communications FDA, FDA Approval

NICE has moved to recommend Roche’s Polivy (polatuzumab vedotin), when combined with rituximab and bendamustine, for the treatment of diffuse …
News

AstraZeneca scores Japanese approval for Imfinzi combo in extensive-stage small cell lung cancer

August 21, 2020 Medical Communications, Sales and Marketing AstraZeneca, Imfinzi, Japan

AstraZeneca’s Imfinzi (durvalumab) has secured approval in Japan for the treatment of extensive-stage small cell lung cancer when combined with etoposide and …
News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

August 21, 2020 Medical Communications COVID-19, coronavirus

The top 10 news stories this week again focus on coronavirus vaccines and treatments, as professor Alexander Chuchalin has quit …
News
fda2outsideweb

FDA panel votes 9-1 in favour of approval for Mesoblast’s Ryoncil in paediatric steroid-refractory acute graft versus host disease

August 14, 2020 Medical Communications, Sales and Marketing FDA, Mesoblast, Ryoncil, pharma

It’s good news for Mesoblast as an expert FDA panel gave a glowing recommendation for the approval in the US …
News
fillip

Philippines expected to approve Russia’s ‘Sputnik’ COVID-19 vaccine

August 14, 2020 Medical Communications COVID, COVID-19, coronavirus, vaccines

The Philippines is expected to begin large scale human testing of Russia’s controversial ‘Sputnik’ coronavirus vaccine. Rodrigo Duterte, the President …
News
shutterstock_244903099

Novavax and Janssen commit 90 million COVID-19 vaccine doses to UK Government with two new deals

August 14, 2020 Manufacturing and Production, Medical Communications, Sales and Marketing COVID-19, J&J, JJ, Novavax, UK, pharma

The UK Government has signed a new deal with Johnson & Johnson and Novavax to secure 90 million orders of …
News
vxxxxeer_0

Top Russian doctor quits over questionable ethics that rushed through coronavirus vaccine approval

August 14, 2020 Medical Communications

Professor Alexander Chuchalin has quit the Russian Health Ministry’s ethics council due to the quick approval process for the country’s …
News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

August 14, 2020 Medical Communications COVID-19, coronavirus, pandemic

The top 10 news stories this week once again focus on coronavirus treatments and vaccines, as President Putin announced that …
News
fake_news

Coronavirus fake news has led to hundreds of deaths, according to a new study

August 13, 2020 Medical Communications COVID, coronavirus, fake news

At least 800 people have died around the world from COVID-19 misinformation in the first three months of 2020, according …
News
christine

Dr Christine Wilkinson Blanc appointed as Chief Medical Officer at Nordic Nanovector

August 10, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Nordic Nanovector has announced that Dr Christine Wilkinson Blanc has been appointed as the Chief Medical Officer of the company.
Appointment
vaccination-1215279_960_720

Early promise from Novavax’s vaccine candidate for COVID-19

August 7, 2020 Medical Communications, Research and Development COVID-19, Novavax, Vaccine

New Phase 1/2 on Novavax’s COVID-19 vaccine candidate NVX‑CoV2373 has shown that the therapy generated “robust antibody responses” when used …
News
covid_innovations_bamc

Researchers at the University of Oxford have said hydroxychloroquine could still be a viable COVID-19 treatment

August 7, 2020 Medical Communications COVID, hydroxychloroquine

Researchers at the University of Oxford have said that hydroxychloroquine could be beneficial to COVID-19 patients, despite a general lack …
News
astrazeneca_building_white

AstraZeneca seals manufacturing deal to deliver COVID-19 vaccine in China

August 7, 2020 Manufacturing and Production, Medical Communications AstraZeneca, COVID-19, China, pharma

AstraZeneca has signed its first deal in China to produce and deliver its vaccine candidate against COVID-19 in the country, …
News
50185852257_94002eda8f_b

Trump signs executive order to direct federal agencies to prioritise purchasing drugs made in the US

August 7, 2020 Manufacturing and Production, Medical Communications, Sales and Marketing FDA, Peter Navarro, Trump, drug prices

US President Donald Trump has signed an executive order which will direct federal agencies to prioritise buying drugs and drug …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025